Kenvue (KVUE) CTO awarded 189,274 RSUs on Form 4, vesting 2026–2028
Kenvue (KVUE) reported an insider transaction on Form 4.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Filing Summary
Kenvue (KVUE) reported an insider transaction on Form 4. The company’s Chief Technology & Data Officer was granted 189,274 restricted stock units on 10/01/2025. Each unit corresponds 1-for-1 to Kenvue common stock and carries an exercise price of $0.
The award vests in three equal installments on 10/01/2026, 10/01/2027, and 10/01/2028, contingent on continued service through each vesting date. Following the grant, 189,274 derivative securities were beneficially owned, reported as Direct (D).
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Restricted Stock Units | 189,274 | $0.00 | $0.00 |
Footnotes (2)
- F1. These units correspond 1 for 1 with the Company's common stock.
- F2. This award vests in three equal installments on 10/01/2026, 10/01/2027, and 10/01/2028, subject to the reporting person's continued service through such vesting date.
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What did Kenvue (KVUE) disclose in this Form 4?
What is the vesting schedule for the KVUE RSU grant?
What price is associated with the KVUE RSUs?
How many derivative securities were owned after the transaction?
Who is the reporting person’s role at KVUE?
AI-generated analysis. How Rhea-AI works. Not financial advice.